News
Recent news about Panacea Capital and select portfolio companies
Clinical Research Consulting vs. FSP in Biotech and Pharma: Knowing When an FSP Is the Right Fit
Clinical Research Consulting vs. FSP: Choosing the Right Model for Biotech and Pharma Companies Biotech…
Clinical Research Consulting vs. FSP in Biotech and Pharma: Knowing When an FSP Is the Right Fit
Clinical Research Consulting vs. FSP: Choosing the Right Model for Biotech and Pharma Companies Biotech…
CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New
HiRO Attending CRM Trial Connect 2026 in Kuala Lumpur HiRO will be attending CRM Trial…
CRM Trial Connect 2026 Kuala Lumpur: Where to Find HiRO and What’s New
HiRO Attending CRM Trial Connect 2026 in Kuala Lumpur HiRO will be attending CRM Trial…
Advancing Cross‑Border Clinical Development: HiRO at BIO Korea 2026
HiRO to Attend BIO Korea 2026, April 28–30 in Seoul HiRO is excited to announce…
Advancing Cross‑Border Clinical Development: HiRO at BIO Korea 2026
HiRO to Attend BIO Korea 2026, April 28–30 in Seoul HiRO is excited to announce…
Meet HiRO at COG New England Conference on April 28-29!
HiRO to Attend COG New England Conference, April 28–29 Clinical development is becoming increasingly global,…
Meet HiRO at COG New England Conference on April 28-29!
HiRO to Attend COG New England Conference, April 28–29 Clinical development is becoming increasingly global,…
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell and Gene Therapy
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell…
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell and Gene Therapy
China’s Order No. 818: What Foreign Biotech Companies Need to Know About IITs for Cell…